Blocking Notch3 Signaling Abolishes MUC5AC Production in Airway Epithelial Cells from Individuals with Asthma.

Saved in:
Bibliographic Details
Title: Blocking Notch3 Signaling Abolishes MUC5AC Production in Airway Epithelial Cells from Individuals with Asthma.
Authors: Reid AT; School of Biomedical Sciences and Pharmacy.; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and., Nichol KS; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and.; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia., Chander Veerati P; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and.; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia., Moheimani F; School of Biomedical Sciences and Pharmacy.; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and., Kicic A; School of Paediatrics and Child Health.; Telethon Kids Institute, and.; Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.; Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, Western Australia, Australia.; Occupation and Environment, School of Public Health, Curtin University, Bentley, Western Australia, Australia., Stick SM; School of Paediatrics and Child Health.; Telethon Kids Institute, and.; Centre for Cell Therapy and Regenerative Medicine, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.; Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, Western Australia, Australia., Bartlett NW; School of Biomedical Sciences and Pharmacy.; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and., Grainge CL; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and.; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia; and., Wark PAB; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and.; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.; Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia; and., Hansbro PM; School of Biomedical Sciences and Pharmacy.; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and., Knight DA; School of Biomedical Sciences and Pharmacy.; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, and.; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Source: American journal of respiratory cell and molecular biology [Am J Respir Cell Mol Biol] 2020 Apr; Vol. 62 (4), pp. 513-523.
Publication Type: Journal Article
Journal Info: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 8917225 Publication Model: Print Cited Medium: Internet ISSN: 1535-4989 (Electronic) Linking ISSN: 10441549 NLM ISO Abbreviation: Am J Respir Cell Mol Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-4989
DOI:10.1165/rcmb.2019-0069OC